Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma
Serum sBCMA was associated not only with BM overt disease, but also with BM detectable or below LOD MRD.
Authors
- John R. Wingard (ORCID: https://orcid.org/0000-0001-7478-5398)
- Derek M. Li
- Edith M. Sampson (ORCID: https://orcid.org/0000-0002-2891-6630)
- Erin Dean (ORCID: https://orcid.org/0000-0003-3153-223X)
- Robert P. Seifert (ORCID: https://orcid.org/0000-0002-4404-8116)
- Tuo Lin
- John W. Hiemenz
- Jack W. Hsu
Institutions
- University of California, Irvine (US)
- University of Florida Health (US)
- University of Florida (US)
- University of California, Irvine Medical Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fonc.2025.1631511
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- International Centre for Bamboo and Rattan